LEESBURG, Fla., Nov. 20, 2016 -- The use of BioTE® hormone replacement therapy can dramatically improve the quality of life for patients suffering from low levels of estrogen and testosterone, reports Buchanan Health Center. The BioTE® unique delivery system offers a consistent release of hormones as needed by the patient. BioTE® has become the preferred delivery system when compared to patches, pills, creams and injections, as patients often report undesirable symptoms from those methods.
Estrogen is necessary for women in order to maintain bone health, enlarge the uterus during childbirth and regulate cholesterol. Estrogen is also critical in reducing calcium loss through interactions with the parathyroid hormone. The onset of menopause in women increases the risk of osteoporosis in women. Reduced levels of estrogen and progesterone can cause problems for women including weight gain, moodiness, depression, hot flashes, dry skin, recurring bladder infections, lack of energy, and difficulty remembering and concentrating. Misdiagnosis and the use of antidepressants can worsen hormone imbalance symptoms.
Testosterone is important for men and women. Low testosterone levels can cause many of the same problems experienced by women, but may also include loss of muscle strength and tone, increase in abdominal fat/waist circumference, erectile dysfunction and reduced sexual desire for men and women.
BioTE® hormone replacement therapy helps both men and women in maintaining levels of estrogen and testosterone and reducing their risk of age-related diseases associated with low-levels of estrogen and testosterone. With the BioTE® method, rice-sized hormone pellets deliver and release bio-identical hormones to patients as needed up to an average of five months after insertion. Both men and women have reported an improved quality of life through a significant reduction in symptoms. BioTE® HRT is preferable to other delivery methods because the hormones are supplied consistently, which prevents unpleasant mood and energy fluctuations in patients. No other hormone delivery system also reduces risk of age-related illnesses.
“BioTE® hormone replacement therapy is an advanced treatment that better serves our patients,” said Dr. Tige Buchanan. “Patients want to maintain consistency in the delivery of estrogen and testosterone to their bodies to avoid a flare-up of symptoms and unusual moodiness or sudden flagging energy levels. Everyone gets older but it is possible to enjoy an improved quality of life with the use of bio-identical hormones and reduce the risk of uncomfortable and sometimes embarrassing symptoms that can impact the self-confidence of our patients.”
Dana Carroll, ARNP of Buchanan Health Center offers treatment to residents of Leesburg, Fruitland Park, Eustis, Tavares, Mount Dora and Umatilla. Buchanan Health Center provides a multi-disciplinary approach combining western and alternative care techniques to address chronic and acute pain in patients and heal the problem from within naturally. Services include chiropractic care, corrective exercises, lifestyle advice, nutritional counseling and massage therapy.
Call (352) 787-8531 to speak with a knowledgeable associate about BioTE® hormone replacement therapy or visit http://buchananhealth.com/ for more details.
Buchanan Health Center, (352) 787-8531


Instagram Outage Disrupts Thousands of U.S. Users
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 



